MedTrace Logo

Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis

NCT06400056 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-05-06

No results posted yet for this study

Summary

AIM OF WORK :

1. Detect the most common fungal strains that cause tinea capitis
2. Detect Different effectiveness of terbinafine in different cases
3. Detect the resistant strains.
4. Detect the mycological and the clinical cure rates upon using systemic terbinafine in treatment of tinea capitis

Conditions

  • Fungal Resistance

Interventions

DRUG

Terbinafine

FDA approved

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Alaa Moubasher, Professor · Supervisor

  • Radwa Bakr, Professor · Supervisor

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2025-04-30
Completion
2025-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06400056 on ClinicalTrials.gov